Therapy of pulmonary hypertension: the evolution from vasodilators to antiproliferative agents

Am J Respir Crit Care Med. 2002 Nov 15;166(10):1308-9. doi: 10.1164/rccm.2208008.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Animals
  • Anticholesteremic Agents / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / pathology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypertension, Pulmonary / drug therapy*
  • Lung / blood supply
  • Lung / drug effects
  • Lung / pathology
  • Simvastatin / therapeutic use
  • Treatment Outcome
  • Vasodilator Agents / therapeutic use

Substances

  • Anticholesteremic Agents
  • Antineoplastic Agents
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Vasodilator Agents
  • Simvastatin